Weixian Zhou
Overview
Explore the profile of Weixian Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng Y, Lin G, Zhou W, Wei L, Liu J, Shang S, et al.
ACS Appl Mater Interfaces
. 2024 Sep;
16(38):51748-51756.
PMID: 39259831
Textiles that can repeatedly change color in the presence of external stimuli have attracted great interest. Effectively designing to produce such functional textiles is essential, yet there remain challenges like...
2.
Ding Y, Hou D, Yin Y, Chen K, He J, Yan S, et al.
Theor Appl Genet
. 2024 May;
137(6):141.
PMID: 38789698
Stable and novel QTLs that affect seed vigor under different storage durations were discovered, and BnaOLE4, located in the interval of cqSW-C2-3, increased seed vigor after aging. Seed vigor is...
3.
Zhou W, Zhang L, He J, Chen W, Zhao F, Fu C, et al.
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003428
Interspecific crosses that fuse the genomes of two different species may result in overall gene expression changes in the hybrid progeny, called 'transcriptome shock'. To better understand the expression pattern...
4.
Zhou W, Rahman M, Sun C, Li S, Zhang N, Chen H, et al.
Adv Mater
. 2023 Sep;
36(14):e2307805.
PMID: 37750196
Peripheral nerve injury potentially destroys the quality of life by inducing functional movement disorders and sensory capacity loss, which results in severe disability and substantial psychological, social, and financial burdens....
5.
He J, Zhang K, Yan S, Tang M, Zhou W, Yin Y, et al.
Genome Res
. 2023 Jun;
33(5):798-809.
PMID: 37290935
The recently constructed mutant libraries of diploid crops by the CRISPR-Cas9 system have provided abundant resources for functional genomics and crop breeding. However, because of the genome complexity, it is...
6.
Zhang Z, Li K, Zhou W, Gu J, Liu Y, Han C, et al.
Front Chem
. 2020 Jun;
8:489.
PMID: 32596208
The most severe problem in bone regeneration is the defect in the interface. We prepared four types of implantation scaffolds of crosslinked gelatin (GE)/hydroxyapatite (HAp) to study the factors influencing...
7.
Bao J, Zhang W, Zhou W, Lv M, Lu C, Yu H
Talanta
. 2020 Apr;
215:120918.
PMID: 32312461
Human epidermal growth factor receptor 2 (HER2)-positive is a particularly aggressive type of the breast cancer. Because of the evidence has revealed that accurate HER2 status detection is crucial for...
8.
Wu J, Zhang Z, Gu J, Zhou W, Liang X, Zhou G, et al.
J Control Release
. 2020 Jan;
320:337-346.
PMID: 31931048
Background: Drug delivery systems based on electrospun fibers have been under development for many years. However, studies of controllable long-term drug release from electrospun membrane systems and the underlying release...
9.
Chen Y, Liu L, Ni R, Zhou W
Adv Clin Chem
. 2019 Jul;
91:123-162.
PMID: 31331487
HER2-positive breast cancer is a particularly aggressive type of breast cancer. Indication of HER2 positivity is essential for its treatment. In addition to a few FDA-approved methods such as immunohistochemical...
10.
Zhou W, Xu F, Li D, Chen Y
Clin Chem
. 2017 Nov;
64(3):526-535.
PMID: 29142051
Background: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is a particularly aggressive type of the disease. To date, much evidence has indicated that accurate HER2 status detection is...